REVIVA PHARMACEUTICALS HOLDINGS, INC. - RVPH
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 16
Latest filed: Aug 12, 2026
| Form | Count |
|---|---|
| 8-K | 7 |
| SCHEDULE 13G/A | 3 |
| SCHEDULE 13G | 3 |
| 4 | 2 |
| SCHEDULE 13D/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 12, 2026 | 8-K | Aug 12, 2026 | 0001437749-26-027356 | View |
| Aug 03, 2026 | SCHEDULE 13G/A | — | 0001104659-26-089899 | View |
| Jul 31, 2026 | SCHEDULE 13G/A | — | 0001610520-26-000096 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001649553-26-000058 | View |
| May 13, 2026 | 8-K | May 13, 2026 | 0001437749-26-016760 | View |
| May 13, 2026 | 8-K | May 12, 2026 | 0001437749-26-016538 | View |
| May 07, 2026 | SCHEDULE 13G | — | 0001610520-26-000060 | View |
| Apr 15, 2026 | 8-K | Apr 15, 2026 | 0001437749-26-012303 | View |
| Mar 30, 2026 | SCHEDULE 13G | — | 0001104659-26-036874 | View |
| Mar 30, 2026 | 8-K | Mar 30, 2026 | 0001437749-26-010140 | View |
| Mar 25, 2026 | SCHEDULE 13G | — | 0001649553-26-000036 | View |
| Mar 24, 2026 | SCHEDULE 13D/A | — | 0001493152-26-012362 | View |
| Mar 20, 2026 | 4 | Mar 18, 2026 | 0001437749-26-009258 | View |
| Mar 20, 2026 | 4 | Mar 18, 2026 | 0001437749-26-009260 | View |
| Mar 19, 2026 | 8-K | Mar 18, 2026 | 0001437749-26-009063 | View |
| Mar 05, 2026 | 8-K | Mar 04, 2026 | 0001437749-26-006991 | View |